AZISAST Study: AZIthromycin in Severe ASThma Study
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety and cost-effectiveness of
azithromycin as add-on therapy in adult subjects with severe persistent asthma, who remain
inadequately controlled despite GINA (2006) step 4 or 5 therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Ghent
Collaborator:
Agentschap voor Innovatie door Wetenschap en Technologie